Clinton the keynote speaker and founder of the organization
He also has a lot of chartible money to dole out
Go to the PR, click on the link and go to the bottom of the page
Is that why the PPS is up pre market? Its a different type of cancer and it doesn't preclude Imetelstat from being part of the treatment
What drop are you talking about? ARIA was down $11.61 and Gern was up 2 cents. The tox problems were made known this morning. I think you're the doobie smoker.
What a moron. Obama started living in Chicago after law school. And what does he have to do with Detroit other than the fact that you associate him with it because of the color of his skin.
I'm with you. I can't wait for this saga to end. I have been successfully (most of the time) investing in stocks since I was 13 years-old with a 2K inheritance. I have gotten a lot of #$%$ about my Geron pick over the years and my first shares @ 7 went to 75 and back down.
Maine, well said. Also, another move Chip made that makes it obvious that Geron won't be around long is stopping all pre-clinical research. Biotechs that plan on being around for a while have a "pipeline" of future therapies. Geron has no pipleline.. just Imetelstat. When he made the move to dump the CSO he must have already had high confidence that Imetelstat was a winner in blood cancer.
In my not so humble opinion. FDA will still require multi-center trail but they could start marketing it soon.
carlos, Chip was wise to stop pursuing solid tumors given results and resources. I bet whatever deep pocket pharma ends up with Imetelstat will investigate solid tumors again.
I like Chips choice of words. He says "disease modifying" where Okarma would pump that its a "cure". There is no need to pump. The results will take care of that.
Given that its unblinded he can probably say anything but he doesn't want to pizz off the lead investigator who is paying for Chip's trial.
blue, the Mayo trial is not blinded. It's open label so patients and care givers know they are getting Imetelstat.
e2w, I doubt a single patient's remission is considered Material information. Patients do recover from what are considered incurable cancers.
With the ACTC Rpe trial at least 2 patients said the bought shares after they were treated. One blogged about it.
It could be. He dropped some major hints suggesting Imetelstat is disease modifying and no MF treatments provide CRs and PRs. This isn't wild speculation on my part. It seems pretty obvious. Since the study isn't blinded its likely additional info is out there that we don't know about.